‹ All Posts

Saurab Jain

Latest posts, stock views and market insights from Saurab Jain on StockGro.

SEBI-Registered Research Analyst · INH000012838 · View advisor profile

Saurab Jain

3 hours ago · SEBI-Registered Analyst

Swiggy Shares Rise After ₹1,041 Crore Institutional Buying

Swiggy shares

SWIGGY
saw notable institutional buying on September 4, 2026, as BNP Paribas Financial Markets and Goldman Sachs Investments Mauritius I acquired shares worth a combined ₹1,041 crore through open-market transactions. BNP Par…

#Miscellaneous#StockInNews#Post-ClosingCommentary
49 likes·48 comments
Saurab Jain

6 hours ago · SEBI-Registered Analyst

Bharat Forge Shares Slide After FN Herstal Defence Tie-Up

Bharat Forge

BHARATFORG
shares declined 1.26% to ₹1,956 on September 4, 2026, extending their losing streak to four consecutive sessions. The stock is now trading near a two-and-a-half-month low as investors weigh the recent correction ag…

#StockInNews#WatchOutFor
99 likes·52 comments
Saurab Jain

11 hours ago · SEBI-Registered Analyst

STLTECH Hits Upper Circuit After ₹3,000 Cr Capex

Sterlite Technologies

STLTECH
hit the 5% upper circuit on Friday, September 4, closing at ₹748.90, after the company’s Board approved a massive ₹3,000 crore capex for its existing manufacturing facility. The investment comes at a time wh…

#StockInNews#Post-ClosingCommentary
170 likes·29 comments
Saurab Jain

5th Sep · SEBI-Registered Analyst

Ramco Systems Gains 4% After Safran Aviation Tie-Up

Ramco Systems has signed a Memorandum of Understanding (MoU) with Safran Helicopter Engines, a leading rotorcraft turbine manufacturer, to collaborate on seamless integration of Safran’s engine data with Ramco Aviation Software. The partne…

#StockInNews#Post-ClosingCommentary
488 likes·72 comments
Saurab Jain

5th Sep · SEBI-Registered Analyst

Gland Pharma: Block Deal Buzz and Stock Performance

GLAND
is back in focus after reports that its promoter, Fosun Pharma Industrial, is likely to sell a 5% equity stake through a block deal. According to CNBC-TV18, citing sources, the proposed deal could be worth around ₹2,279.5 crore, wi…

#StockInNews#WatchOutFor#Post-ClosingCommentary
468 likes·77 comments
Saurab Jain

5th Sep · SEBI-Registered Analyst

IEX: Strong August Volumes, But Stock Ends in Red

Indian Energy Exchange (

IEX
) witnessed strong growth in trading volumes during August, according to its latest monthly business update. However, despite the positive operational numbers, the stock’s initial gains failed to sustain. IEX…

#WatchOutFor#StockInNews
601 likes·65 comments
Saurab Jain

4th Sep · SEBI-Registered Analyst

UltraTech’s Wires Entry Puts Pressure on cable stocks

UltraTech Cement’s entry into the wires and cables segment with its new Ultravolt brand has put pressure on established players. Shares of wires and cables companies came under pressure on Friday, September 4, after UltraTech Cement entere…

#StockInNews#Post-ClosingCommentary
801 likes·45 comments
Saurab Jain

4th Sep · SEBI-Registered Analyst

Cipla Key U.S. Biosimilar Deal Amid Stock Weakness

Cipla (

CIPLA
) has a subsidiary, Invagen Pharmaceuticals Inc., that has entered into a strategic partnership with Qilu Pharmaceutical Co. for the exclusive licensing and supply of QL2107, a biosimilar to Keytruda (pembrolizumab), in the U…

#WatchOutFor#StockInNews#Post-ClosingCommentary
457 likes·49 comments
Saurab Jain

4th Sep · SEBI-Registered Analyst

Cohance Lifesciences Investment Push for ADC Growth

COHANCE
Cohance Lifesciences is stepping up its focus on the high-potential Antibody-Drug Conjugate (ADC) segment with two proposed strategic transactions. The company plans an additional $13 million investment in NJ Bio and a $5 million…

#StockInNews#WatchOutFor
461 likes·72 comments
Saurab Jain

3rd Sep · SEBI-Registered Analyst

Apar Industries 5% Rally After Four Negative Sessions

Apar Industries (

APARINDS
) bounced back strongly today, September 3, 2026, closing at ₹17,704, up 5.3% or ₹891. The rally comes after four consecutive negative closing sessions, putting the stock back in focus. The stock is now trading…

#Post-ClosingCommentary#EquityResearch
492 likes·78 comments
Saurab Jain

3rd Sep · SEBI-Registered Analyst

HEXT Leadership Transition and Stock Outlook

Hexaware Technologies

HEXT
has announced a major leadership transition. Vivek Jetley has been appointed CEO-designate and will take charge as CEO on October 28, 2026. Current CEO Srikrishna Ramakarthikeyan will step down as CEO and from…

#StockInNews#WatchOutFor
887 likes·76 comments
Saurab Jain

3rd Sep · SEBI-Registered Analyst

Altius Telecom, Pine Labs See Mega Block Deals

Several notable bulk and block deals took place across companies, involving institutional investors, promoters and global funds.

PINELABS
: Alpha Wave Ventures II LP sold 3.54 crore shares, or 3.07% stake, for ₹549.92 crore at ₹155.10 per…

#StockInNews#WatchOutFor
838 likes·76 comments
Saurab Jain

2nd Sep · SEBI-Registered Analyst

IFCI and NIACL Shares Rise on NSE IPO Buzz

Shares of New India Assurance Company Ltd (

NIACL
) and IFCI Ltd (IFCI) surged in Wednesday’s trading session amid market buzz that the National Stock Exchange (NSE) could launch its much-awaited IPO by the end of this month. Unconfirmed…

#Post-ClosingCommentary#WatchOutFor
892 likes·50 comments
Saurab Jain

2nd Sep · SEBI-Registered Analyst

Gland Pharma Shares Recover volatile USFDA Inspection

GLAND
shares came under pressure on September 2, 2026, falling as much as 2.5% during the session, before recovering the entire decline and trading largely flat in afternoon trade. At around 3:18 PM IST, the stock was quoted at ₹2,873.90,…

#WatchOutFor#StockInNews
570 likes·29 comments
Saurab Jain

2nd Sep · SEBI-Registered Analyst

Hero MotoCorp Stock Falls Despite August Sales Growth

Shares of

HEROMOTOCO
Hero MotoCorp declined over 6% today, with the stock under pressure amid broader market concerns, including the sharp rise in crude oil prices. The August sales data also offered a mixed picture for India’s largest two…

#Miscellaneous#TrendingSectors
858 likes·59 comments
Saurab Jain

31st Aug · SEBI-Registered Analyst

Stocks Will Be in Focus: Aurobindo Pharma, Cipla, HDFC Bank

AUROPHARMA
: The US FDA inspected Unit-VI, an API manufacturing facility of the company’s subsidiary Apitoria Pharma, at Anakapalli, Andhra Pradesh, from August 24 to 28, 2026. The inspection concluded with three observations, which are pr…

#StockInNews#WatchOutFor
688 likes·64 comments
Saurab Jain

30th Aug · SEBI-Registered Analyst

BEML Strong Opportunities Across Key Segments

BEML
BEML continues to benefit from opportunities across Defence, Mining & Construction, and Rail & Metro segments. Rising government spending on defence and infrastructure could support the company’s order pipeline and long-term growth. I…

#IndexStrategies
1,196 likes·54 comments
Saurab Jain

30th Aug · SEBI-Registered Analyst

Kec International Debt Reduction Support Business Visibility

RKEC
KEC International continues to strengthen its position across Transmission & Distribution, Civil, Renewables, Cables & Conductors and Transportation. The company reported order intake of ₹6,303 crore in Q1 FY27, while its order book a…

#StockInNews
1,180 likes·44 comments
Saurab Jain

30th Aug · SEBI-Registered Analyst

Defence Stocks Fall on Export Rule Changes

Defence Stocks Slide as Easier Exports Raise Competition Concerns Defence stocks came under pressure on Friday after the government opened the General Export Licence (GEL) framework and simplified defence export procedures. Bharat Dynamics…

#FundamentalViews#Post-ClosingCommentary
736 likes·79 comments
Saurab Jain

29th Aug · SEBI-Registered Analyst

Apollo Tyres Steady After ₹1,175 Crore Block Deal

Shares of

APOLLOTYRE
closed almost flat on Friday, August 28, 2026, ending at ₹443.50, up marginally by 0.06%. The muted market reaction came as Emerald Sage Investment, an investment vehicle owned by global private equity firm Warburg P…

#StockInNews#WatchOutFor
1,177 likes·63 comments